Ministry of Commerce & Industry, Department of Commerce, Directorate General of Foreign Trade, has issued a significant amendment through Notification No. 72/2023, dated 11th March, 2024. This amendment specifically targets the export policy of Human Biological Samples under Chapter 30 of the ITC HS Schedule-2.
Export Policy of Human Biological Samples under Chapter 30 of [ITC HS schedule-2 of export policy is amended to the extent that export of item that contains Human biological materials/samples/products under chapter 30 is free subject to the NOC from Central Drugs Standard Control Organization (CDSCO) or Indian Council of Medical Research (ICMR). Department of Health Research (DHR).
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Vanijya Bhawan, New Delhi
Notification No. 72/2023-DGFT | Dated : 11thMarch, 2024
Subject: Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy.
S.O. 1249(E).—In exercise of powers conferred by Section 3 read with section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2023, the Central Government hereby amends Export Policy under chapter 30 related to Human Biological Samples, as under:
|
HS Code |
Item Description | Revised Export Policy | Revised Policy Condition |
| 30021020 | Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes | Free subject to NOC | 1. Any human biological materials/samples/products which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO.
2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DIIR. |
| 30021091 | Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes | ||
| 30021210 | For diphtheria | ||
| 30021220 | For tetanus | ||
| 30021230 | For rabies | ||
| 30021240 | For snake venom | ||
| 30021290 | Other | ||
| 30029010 | Human Blood |
2. Effect of the Notification:
Export Policy of Human Biological Samples under Chapter 30 of [ITC HS schedule-2 of export policy is amended to the extent that export of item that contains Human biological materials/samples/products under chapter 30 is free subject to the NOC from Central Drugs Standard Control Organization (CDSCO) or Indian Council of Medical Research (ICMR). Department of Health Research (DHR).
(Santosh Kumar Sarangi)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: dgft@nic.in
(Issued from F. No. 01/91/191/48/AM23/EC/e-35188)
